Cima Hospice Of The Valley Lp Medicare Approved Location: 3524 W Alberta Road, Edinburg, Texas 78539 Phone: (956) 631-4354 |
Allstate Hospice Llc Medicare Approved Location: To 4622 S Closner, Edinburg, Texas 78539 Phone: (956) 287-8585 |
Amara Hospice Medicare Approved Location: 505 West Owassa Road, Edinburg, Texas 78539 Phone: (956) 283-1550 |
Harbor Hospice Of Mcallen Lp Medicare Approved Location: 5407 South Mccoll Road Unit A, Edinburg, Texas 78539 Phone: (361) 579-7120 |
News Archive
With rates of Clostridium difficile (C. difficile) now rivaling drug-resistant Methicillin-resistant Staphylococcus aureus (MRSA) as the most common bacteria to cause healthcare-associated infections, new expert guidance encourages healthcare institutions to implement and prioritize prevention efforts for this infectious diarrhea.
New research shows that the widely used pain reliever acetaminophen may be associated with an increased risk of asthma and wheezing in both children and adults exposed to the drug. Researchers from the University of British Columbia, Vancouver, BC, Canada, conducted a systematic review and metaanalysis of 19 clinical studies (total>The analysis showed that the pooled odds ratio (odds ratio for all studies combined) for asthma among users of acetaminophen was 1.63.
Researchers from Boston University School of Medicine in collaboration with investigators at the University of Utah, have discovered a new approach for identifying smokers at the highest risk for developing lung cancer. The findings, which appear in the April 7th issue of Science Translational Medicine, will allow the researchers to use a genomic approach to prevent lung cancer in these individuals and to personalize cancer chemoprophylaxis and therapy.
A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physiology of the Keio University School of Medicine, together with a research group of Eisai Co., Ltd. has identified a compound that has the potential to be a treatment for Parkinson's disease by using dopaminergic neurons differentiated from induced pluripotent stem (iPS) cells from patients with familial Parkinson's disease.
Stanley, Inc., a leading provider of systems integration and professional services to the U.S. federal government, today announced that it was awarded two time-and-materials contracts valued at $15 million, with exercise of options, by the U.S. Department of Health and Human Services (DHHS), Office of the National Coordinator (ONC). These two awards follow an award from DHHS that the company announced on August 2, 2010, to provide operation and infrastructure support for the Nationwide Health Information Network. All three awards fall under the company's Chief Information Officer – Solutions and Partners 2 Innovations contract with the National Institutes of Health Information Technology Acquisition and Assessment Center (NITAAC).
› Verified 8 days ago